Clinical Trials Browser

Phase 1 × Unknown × Biological Products × Clear all

NCT03383952 2017-12-27

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03383965 2017-12-27

CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

Phase 1 Unknown

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic